Sentri7 helps hospitals continuously improve the appropriate use of antibiotics by arming clinicians with information to prevent harm while minimizing drug costs.
This evidence-based, out-of-the-box solution helps you monitor patients in real-time, optimize antimicrobial therapies, and analyze performance in key areas:
Use Sentri7® and its turnkey SoleSource platform to inform continuous improvement, streamline adoption of programs, policies, and procedures – and increase the impact of your pharmacy programs across facilities.
Are you ready for AUR Reporting next year?
CMS has incorporated Antimicrobial Use and Resistance (AUR) reporting to National Health and Safety Network (NHSN) as a required element under the Public Health reporting category within Promoting Interoperability Program beginning in 2024. Talk to your Quality leader about the AUR reporting requirement to determine how to avoid penalties for non-reporting.
To qualify for the Promoting Interoperability program credit, AUR reports must be submitted to the NHSN by a vendor—like Sentri7® Pharmacy AMS—certified for AUR reporting by the ONC and listed on the Certified Health IT Product List (CHPL).
Bayesian Dosing for Vancomycin and other medications
REDUCE VARIATION IN CARE
Aultman Hospital relies on Sentri7 to improve the hospital's ASP performance
Aultman Hospital’s adoption of Sentri7 enabled pharmacy leadership to regularly track overall antibiotic spending, particularly on high cost and broad-spectrum antibiotics like daptomycin. Aultman was able to integrate its EHR and set up antimicrobial stewardship rules and workflows to prioritize patients in real-time in a centralized dashboard, taking the guesswork out of where the pharmacy team could make the biggest impact on care. That’s the Sentri7 difference.
Learn more about Aultman Hospital’s experience with Sentri7.
Explore more of the Sentri7 difference and its impact on healthcare facilities.
A large health system targets high-cost antibiotics to decrease pharmacy spend
Identifying ertapenem (INVANZ) as a target for five key hospitals, a large health system utilized Sentri7 clinical surveillance to track daily prescribing over the course of a year in the inpatient setting with the goal of substituting to meropenem due to its lower cost and better overall spectrum of activities. The health system was able to decrease overall ertapenem vials thereby reducing spend on this high-cost antibiotic and upholding each hospital's commitment to high-quality care. That’s the Sentri7 difference.
Learn more about this health system’s experience with Sentri7.
Explore more of the Sentri7 difference and its impact on healthcare facilities.
Pediatric hospital standardizes pharmacy clinical practices
A nationally recognized pediatric hospital relies on Sentri7’s turnkey evidence-based library to establish a set of rules and metrics to strengthen the pharmacy’s impact on the hospital’s key initiatives, including its antimicrobial stewardship program (ASP) and management of drug spend. Reduce pharmacy spending through medication therapy adjustments, increased pharmacist dose evaluations and de-escalation of high-cost medications. Achieving an additional $1.2 million in hard-cost savings. That’s the Sentri7 difference.
Learn more about this pediatric hospital’s experience.
Explore more of the Sentri7 difference and its impact on healthcare facilities.
Leverage metrics to improve your ASP
